A comprehensive view of gsk group (glaxosmithkline). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
Fitch affirms GlaxoSmithKline's A- long-term issuer default rating with stable outlook, driven by strong diversification, improving profitability and free cash flow; financial flexibility expected to improve after split of its consumer-health division
Published:
June 23, 2022
by ENP Newswire
|
“Chelating Platform For Delivery Of Radionuclides” In Patent Application Approval Process (USPTO 20220160904)
Published:
June 14, 2022
by Cancer Daily
|
Glaxosmithkline Biologicals Files United States Patent Application For Novel Influenza Antigens
Published:
June 14, 2022
by Pharmaceutical Patent News
|
GlaxoSmithKline to acquire Affinivax for US$2.1B and its bacterial infectious disease vaccine under development that targets 24 species of Streptococcus pneumoniae; pneumococcal vaccine market projected to grow to US$10B by 2028
Published:
June 10, 2022
by Chemie Aktuell (CBNB Abstracts)
|
Gsk Announces Positive Phase Iii Data For Rsv Vaccine Candidate For Older Adults
Published:
June 10, 2022
by CE Noticias Financieras (Latin America)
|
Ask us about our Health Care Sector market view
Trending Chart
Interactive chart with headline count